Skip to content

The value of traditional Chinese medicine in the dialectical treatment of azoospermia: a randomized controlled study

Value of traditional Chinese medicine in dialectical treatment of idiopathic spermatogenic stagnation non obstructive azoospermia: a randomized controlled study

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2200006049
Enrollment
Unknown
Registered
2022-06-01
Start date
2021-01-01
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Male infertility

Interventions

Chinese herbal medicine treatment group:Chinese herbal medicine treatment
Placebo control group:Placebo treatment

Sponsors

NHC Key Laboratory of Male Reproduction and Genetics, Guangdong Provincial Reproductive Science Institute (Guangdong Provincial Fertility Hospital), Human Sperm Bank of Guangdong Province
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
20 Years to 40 Years

Inclusion criteria

Inclusion criteria: ? Patients aged 20-40 years; ? Azoospermia was determined according to the fifth edition of who manual for laboratory testing of human semen; ? The clinical diagnosis meets the diagnostic criteria of NOA; ? Testicular biopsy report was consistent with the diagnosis of NOA of spermatogenic arrest; ? No cytotoxic drugs or radioactive substances were used in recent 3 months, and the chromosome and AZF gene were normal; ? The development of the second sexual sign is normal, and there is no malformation in the external reproduction; ? Be able to follow up and cooperate with inspection; ? Conform to various dialectical constitutions.

Exclusion criteria

Exclusion criteria: ? Excluding infectious diseases, mental diseases, genetic diseases, endocrine diseases and other systemic diseases; ? Exclude the history of mumps, cryptorchidism and indirect hernia; ? Those who do not meet the inclusion criteria; ? Congenital absence of vas deferens; ? Non compliance with medical advice and poor compliance; ? Those who can't check, follow-up and cooperate with the inspection, and withdraw themselves in the middle; ? Those who are allergic to the drugs used in this study and are not suitable for treatment.

Design outcomes

Primary

MeasureTime frame
Sperm parameters;Reproductive hormone;Testicular pathology;

Countries

China

Contacts

Public ContactHuang Liu

NHC Key Laboratory of Male Reproduction and Genetics, Guangdong Provincial Reproductive Science Institute (Guangdong Provincial Fertility Hospital), Human Sperm Bank of Guangdong Province

k114@163.com13929586046

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026